Injectable Drug Delivery Resources

31. Microphysiological Systems: Closing The Gap Between Models And Medicine 9/2/2025

    Microphysiological systems (MPS) use human cells to model tissue function, offering faster, more predictive insights for drug discovery, safety testing, and personalized medicine—bridging gaps left by animal and 2D models.

32. The Future Of CDMOs: Aseptic Filling Solutions For Growth And Innovation 9/15/2023

    The rapid rise of highly targeted cell and gene treatments requiring small batch production necessitates a new path forward for biologics manufacturing and directly impacts the CMO/CDMO landscape.

33. 5 Ways Pre-Filled Syringes Contribute To Better Patient Outcomes 5/23/2025

    In our series on pre-filled syringes, we explore five key ways this delivery format is enhancing patient outcomes, not just through the medicine it contains, but through the device design itself.

34. Wet Milling Vs. Dry Milling In The Pharmaceutical Industry 8/10/2022

    Read about the considerations necessary for choosing between wet milling and dry milling for a specific active pharmaceutical ingredient.

35. Delivering The Promise Of Gene Therapy 1/22/2024

    Gene therapies rely on efficient, precise methods of delivering genetic material. Examine how combining polymeric nanoparticles with CRISPR therapies is increasing the potential for improved treatment.

36. Understanding Injectable Drug Container Closure Systems 6/20/2024

    Choosing the right container closure system (CCS) format is crucial, so understanding the different parts involved, their functions, storage requirements, and how they impact administering the drug is essential.

37. Maintaining Superior Viral Vector Recovery In Cell And Gene Therapy Applications 9/3/2024

    A study assessing the stability of vials aimed to determine if the vial material had any influence on the viral titer and particle counts of the AAV serotypes.

38. Characterizing Injection Factors And Their Impact On System Function 2/9/2022

    The transition of intravenous in-clinic chronic disease therapies to large volume subcutaneous injections in alternate settings has created an evolving roster of new formulations and treatment options.

39. A Smart, Data-Driven Approach To Formulate Biotherapeutics For PFS 3/5/2024

    Explore a unique model to predict injection force designed to decorrelate factors linked to formulation development and the ones linked to container and delivery device selection.

40. How Recent Trends Impact Bringing Your Molecule To Market 7/9/2024

    With accelerated approval times, growing competition between drugs, and a shift from hospital to home care, you’re under pressure to develop a delivery device in parallel with your drug.